Kolexia
Le Bras Fabien Hématologie
Le Bras Fabien
Hématologie
Hôpital Henri Mondor
Créteil, France
130 Activités
692 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Amyloïdose Amylose à chaine légère d'immunoglobuline Lymphome B Lymphome T Maladie de Hodgkin Paraprotéinémies Lymphome T périphérique Myélome multiple

Collaborateurs

Voir plus
Haioun Corinne
Haioun Corinne
Hôpital Henri Mondor, Créteil, France
Belhadj-Merzoug Karim
Belhadj-Merzoug Karim
Hôpital Henri Mondor, Créteil, France
Damy Thibaud
Damy Thibaud
Hôpital Henri Mondor, Créteil, France
Dupuis Jehan
Dupuis Jehan
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
Gilead
8 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2022
Amgen
2 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
ESC heart failure   05 mars 2024
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome. A DESCAR-T study.
Blood advances   04 janvier 2024
Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries
65th ASH Annual Meeting Abstracts   02 novembre 2023
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
PREVALENCE AND FEATURES OF INFLAMMATORY DEMYELINATING POLYNEUROPATHIES ASSOCIATED WITH BRENTUXIMAB-VEDOTIN THERAPY: A RETROSPECTIVE COHORT STUDY
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
IgG4-related disease and small lymphocytic lymphoma.
QJM : monthly journal of the Association of Physicians   31 juillet 2023
Transfusion needs after CD19 CAR T-cells for large B-cell lymphoma: Predictive factors and impact on outcome
Abstracts of the 33rd Regional Congress of the ISBT Gothenburg, Sweden 17–21 June 2023   12 juin 2023